Literature DB >> 20880565

Membrane raft association of the Vpu protein of human immunodeficiency virus type 1 correlates with enhanced virus release.

Autumn Ruiz1, M Sarah Hill2, Kimberly Schmitt1, Edward B Stephens1,2.   

Abstract

The Vpu protein of human immunodeficiency virus type 1 (HIV-1) is known to enhance virion release from certain cell types. To accomplish this function, Vpu interacts with the restriction factor known as bone marrow stromal cell antigen 2 (BST-2)/tetherin. In this study, we analyzed whether the Vpu protein is associated with microdomains known as lipid or membrane rafts. Our results indicate that Vpu partially partitions into detergent-resistant membrane (DRM) fractions when expressed alone or in the context of simian-human immunodeficiency virus (SHIV) infection. The ability to be partitioned into rafts was observed with both subtype B and C Vpu proteins. The use of cholesterol lowering lovastatin/M-β-cyclodextrin and co-patching experiments confirmed that Vpu can be detected in cholesterol rich regions of membranes. Finally, we present data showing that raft association-defective transmembrane mutants of Vpu have impaired enhanced virus release function, but still maintain the ability to down-regulate CD4.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20880565      PMCID: PMC4104719          DOI: 10.1016/j.virol.2010.08.031

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  60 in total

1.  Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity.

Authors:  I Rousso; M B Mixon; B K Chen; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly.

Authors:  S N Manié; S de Breyne; S Debreyne; S Vincent; D Gerlier
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.

Authors:  D H Nguyen; J E Hildreth
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 4.  The Vpu protein: new concepts in virus release and CD4 down-modulation.

Authors:  Autumn Ruiz; John C Guatelli; Edward B Stephens
Journal:  Curr HIV Res       Date:  2010-04       Impact factor: 1.581

5.  A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.

Authors:  C McCormick-Davis; S B Dalton; D R Hout; D K Singh; N E Berman; C Yong; D M Pinson; L Foresman; E B Stephens
Journal:  Virology       Date:  2000-06-20       Impact factor: 3.616

6.  Sphingomyelin-enriched microdomains at the Golgi complex.

Authors:  I Gkantiragas; B Brügger; E Stüven; D Kaloyanova; X Y Li; K Löhr; F Lottspeich; F T Wieland; J B Helms
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

7.  Analysis of the transmembrane domain of influenza virus neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft association.

Authors:  S Barman; D P Nayak
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles.

Authors:  Jayanta Bhattacharya; Paul J Peters; Paul R Clapham
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Nanoscale organization of multiple GPI-anchored proteins in living cell membranes.

Authors:  Pranav Sharma; Rajat Varma; R C Sarasij; Karine Gousset; G Krishnamoorthy; Madan Rao; Satyajit Mayor
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

10.  Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells.

Authors:  A Pralle; P Keller; E L Florin; K Simons; J K Hörber
Journal:  J Cell Biol       Date:  2000-03-06       Impact factor: 10.539

View more
  11 in total

Review 1.  New insights into HIV assembly and trafficking.

Authors:  Muthukumar Balasubramaniam; Eric O Freed
Journal:  Physiology (Bethesda)       Date:  2011-08

2.  Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.

Authors:  Lisa A Lopez; Su Jung Yang; Colin M Exline; Srinivas Rengarajan; Kevin G Haworth; Paula M Cannon
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

3.  Roles played by capsid-dependent induction of membrane curvature and Gag-ESCRT interactions in tetherin recruitment to HIV-1 assembly sites.

Authors:  Jonathan R Grover; G Nicholas Llewellyn; Ferri Soheilian; Kunio Nagashima; Sarah L Veatch; Akira Ono
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

Review 4.  Modulation of HIV-1-host interaction: role of the Vpu accessory protein.

Authors:  Mathieu Dubé; Mariana G Bego; Catherine Paquay; Éric A Cohen
Journal:  Retrovirology       Date:  2010-12-22       Impact factor: 4.602

5.  Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.

Authors:  Mingyu Lv; Jiawen Wang; Xiaodan Wang; Tao Zuo; Yingzi Zhu; Wei Kong; Xianghui Yu
Journal:  PLoS One       Date:  2011-06-02       Impact factor: 3.240

6.  Function of membrane rafts in viral lifecycles and host cellular response.

Authors:  Tadanobu Takahashi; Takashi Suzuki
Journal:  Biochem Res Int       Date:  2011-12-07

7.  Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism.

Authors:  Juan F Arias; Yukie Iwabu; Kenzo Tokunaga
Journal:  Front Microbiol       Date:  2011-12-12       Impact factor: 5.640

8.  In silico investigations of possible routes of assembly of ORF 3a from SARS-CoV.

Authors:  Hao-Jen Hsu; Wolfgang B Fischer
Journal:  J Mol Model       Date:  2011-05-04       Impact factor: 1.810

9.  Evidence that Vpu modulates HIV-1 Gag-envelope interaction towards envelope incorporation and infectivity in a cell type dependent manner.

Authors:  Archana Gautam; Jayanta Bhattacharya
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation.

Authors:  Ruth Rollason; Katie Dunstan; Peter G Billcliff; Paul Bishop; Paul Gleeson; Helen Wise; Paul Digard; George Banting
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.